By Derek Ishaque
Pharmacy News
March 02, 2013

FDA Clears Monthly Injectable Form Of Aripiprazole.

  Reuters (3/1, Pierson, Lau) reports that the injectable form of aripiprazole is designed to prevent schizophrenia symptom relapses over the long term and should help foster medication compliance in patients who would be less likely to take more frequent doses of medicine.

Author Description

Derek Ishaque

Derek is the Owner and CEO of SCRx Pharmacy. He has previous experience in Investment Banking at Bear Stearns and private equity at Bridgescale Partners. Derek has a B.S. in Finance from USC.

Stay Informed

Sign up to receive the latest news about SCRx services, the industry and more.

Contact Us

Call us with your questions